Treatment of Vedolizumab With Exclusive Enteral Nutrition in Adult Patients With Moderate to Severe Crohn's Disease (Crohn Exclusive Enteral Nutrition Study)
VDZ with concomitant 16-week EEN might be an effective and optimized approach with solid efficacy in the induction and maintenance treatment of active CD.
Authors
- Jian Kang (ORCID: https://orcid.org/0000-0001-9998-4975)
- Anning Yin (ORCID: https://orcid.org/0000-0001-7985-8170)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-0313-6857)
- Li‐Ping Zou (ORCID: https://orcid.org/0000-0001-7233-9378)
- Huipeng Wan
- Jiao Li (ORCID: https://orcid.org/0000-0002-5724-727X)
- Juan Su (ORCID: https://orcid.org/0000-0001-7035-2560)
- Jing Wang (ORCID: https://orcid.org/0000-0003-2078-137X)
- Haixia Ren
- Zhishun Tang (ORCID: https://orcid.org/0000-0001-7133-6909)
- Ping An (ORCID: https://orcid.org/0000-0002-0018-2233)
- Yaqing Xu
- Qian Zhou (ORCID: https://orcid.org/0000-0002-9664-2619)
- Wei Wang (ORCID: https://orcid.org/0009-0006-4755-1194)
- Yang Wang (ORCID: https://orcid.org/0000-0002-9694-2267)
Institutions
- Wuhan University (CN)
- Hubei University of Arts and Science (CN)
- Zero to Three (US)
- Xiangyang Central Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
- Wuhan Sports University (CN)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.14309/ctg.0000000000000759
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province